Zhang Boya, Pei Guanghui, Zhang Yamin, Wang Zhiping, Wang Lianjiang, Xie Yan, Wang Jinshan, Wang Shusen
Organ Transplantation Center, Tianjin First Center Hospital, Tianjin 300192, China (Zhang BY, Zhang YM, Wang ZP, Wang LJ); Tianjin Clinical Research Center for Organ Transplantation, Tianjin 300192, China (Pei GH, Wang SS); Key Laboratory for Critical Care Medicine of Ministry of Health, Tianjin 300100, China (Xie Y, Wang JS). Corresponding author: Wang Shusen, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Aug;29(8):750-751. doi: 10.3760/cma.j.issn.2095-4352.2017.08.016.
The percutaneous transhepatic portal approach is the most commonly used technique for islet transplantation, largely owing to its safety and minimally invasive characteristic. Bleeding complications after islet transplantation are rare. A case of type 1 diabetes mellitus (T1DM) was treated in Tianjin First Center Hospital, who had a massive intra-abdominal hemorrhage after percutaneous transhepatic portal vein catheterization for islet transplantation. Through the review of the overall development of the case, we aim to improve the awareness of the complications of islet transplantation, to reduce the incidence of complications after percutaneous transhepatic portal vein transplantation, and to provide experience.
经皮经肝门静脉途径是胰岛移植最常用的技术，这主要归功于其安全性和微创特性。胰岛移植后的出血并发症很少见。天津第一中心医院收治了1例1型糖尿病（T1DM）患者，该患者在经皮经肝门静脉导管插入术进行胰岛移植后发生了大量腹腔内出血。通过回顾该病例的整体发展过程，我们旨在提高对胰岛移植并发症的认识，降低经皮经肝门静脉移植术后并发症的发生率，并提供经验。
